Pharmaceutical Sciences


A Pharmaceutical Composition Useful for the Treatment of Benign Prostate Hyperplasia


Medical Sciences, Pharmaceutical Sciences

Focus Area:

Treatment of Benign Prostate Hyperplasia


GB2443588, CN101267859, EP1933945

Social Benefits:

Can be made available in wide ranging formulations pharmaceutical composition is in an oral, intravenous, intramuscular, or subcutaneous formulation for using various delivery routes High specificity of the extract and mahanine for inducing apoptosis in prostate cancer cells No indication of any toxicity, other cells such as hepatocytes, cardiomyocytes, and skeletal muscle are not killed by the pharmaceutical composition of this invention The pharmaceutically active fraction can be extracted from any plant parts be it leaves, stems, fruits, or any other part of the Murraya koenigii. Simplified method of bioactive extraction and a simplified fast and inexpensive process for the preparation of fraction mahanine possessing significantly high biological activities relevant to treatment, relief and remedy of prostate cancer Pharmaceutical composition which is highly compatible for human consumption

Developing Agency:

CSIR-Indian Institute of Chemical Biology (IICB), West Bengal

Technology Readiness Index:

Market Launch

Website Link :
Source (more info) :

Brief Description

Description :

A method for use of a compound mahanine in the treatment of benign prostate hyperplasia and prostate diseases.

Related Technologies